Lesya Sergeyevna Bindas, NP

Offices

1 location

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lesya Sergeyevna Bindas’s office at (253) 292-5133 to ask if they take your plan before you enroll.

State licence records

2 licences

Washington ARNP.AP.60966586-NPAdvanced Registered Nurse Practitioner License · since 2019 · expires 2028-05-06
ActiveNo board action on this licenceCheck it with the state
Washington RN.RN.60557508Registered Nurse License · since 2015 · expires 2027-05-06
ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Original Medicare doctor bills

$10,270

Medicare paid this office $10,270 for 22 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	18	$9,300	$74

Who their Medicare patients are

22 Original Medicare patients in 2024. Average age 57 · Under 65 50% · Health risk score 1.24. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: Depression 55%.

The office billed $49,982, Medicare allowed $14,911 and paid $10,270; for 557 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	22	557	57	1.24	$49,982	$10,270
2023	33	194	50	1.25	$48,723	$12,973
2022	48	219	45	1.09	$46,337	$12,850
2021	41	193	47	1.17	$44,441	$13,574
2020	25	110	57	1.52	$24,881	$6,354

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	31	$10,958	$75

2022: 2 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	33	$7,452	$68
Telephone medical discussion with physician, 21-30 minutes	21	$3,233	$58

2021: 1 service

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	36	$10,762	$77

2020: 1 service

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	21	$4,419	$66

Medicaid work

$128,736 in 2024

Medicaid paid $128,736 for 1,190 billed services this clinician did in 2024, up to 94 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Return visit (30+ min)	1,135	$120,804
Long return visit (40+ min)	27	$5,245
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	28	$2,688

Sort by

Medicaid work by year

2024	1,190	3	94	$128,736
2023	969	1	86	$88,098
2022	1,353	4	82	$120,153
2021	1,296	4	95	$107,303
2020	636	6	62	$55,079

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Return visit (30+ min)	969	$88,098

2022

Sort by

Largest Medicaid services in 2022

Return visit (30+ min)	1,230	$115,233
Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion	92	$2,239
Long return visit (40+ min)	15	$1,779
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	16	$902

2021

Sort by

Largest Medicaid services in 2021

Return visit (30+ min)	1,192	$103,063
New patient visit (60+ min)	30	$3,902
Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion	15	$338
Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease	59	$0

2020

Sort by

Largest Medicaid services in 2020

Return visit (30+ min)	513	$45,387
DOM/R-HOME E/M EST PT LW MOD SEVERITY 25 MINUTES	63	$5,962
Long return visit (40+ min)	14	$1,438
Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion	19	$786
Short return visit (20+ min)	15	$782
Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion	12	$724

Drugs they prescribed that Part D paid

$410,156

Pharmacies billed $410,156 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,518) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.

2,366 generic and 152 brand-name prescriptions · $410,156 in drug cost · 129 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Invega Sustenna	60	$209,195	$3,487
Lybalvi	53	$78,112	$1,474
Abilify Maintena	18	$52,420	$2,912
Clozapine	107	$9,555	$89
Paliperidone Er	16	$6,321	$395

See all 45 drugs

Sort by

Every Part D drug this clinician prescribed

Invega Sustenna	60	$209,195	$3,487
Lybalvi	53	$78,112	$1,474
Abilify Maintena	18	$52,420	$2,912
Clozapine	107	$9,555	$89
Paliperidone Er	16	$6,321	$395
Olanzapine	144	$2,969	$21
Divalproex	81	$2,767	$34
Prazosin	126	$2,542	$20
Bupropion Xl	65	$2,217	$34
Buspirone	115	$2,204	$19
Atomoxetine	19	$2,167	$114
Aripiprazole	102	$2,033	$20
Fluphenazine	50	$1,675	$34
Olanzapine Odt	22	$1,544	$70
Duloxetine	83	$1,526	$18
Hydroxyzine Pamoate	113	$1,446	$13
Risperidone	117	$1,413	$12
Haloperidol	86	$1,370	$16
Trazodone	152	$1,238	$8
Hydroxyzine	44	$1,144	$26
Benztropine Mesylate	104	$1,054	$10
Ziprasidone	17	$1,045	$61
Gabapentin	59	$1,013	$17
Lamotrigine	50	$953	$19
Divalproex Sodium Er	45	$914	$20
Naltrexone	16	$819	$51
Sertraline	100	$750	$7
Mirtazapine	51	$708	$14
Atropine Sulfate	11	$631	$57
Lithium Carbonate	41	$500	$12
Venlafaxine Hcl Er	42	$410	$10
Vilazodone	11	$405	$37
Fluvoxamine Maleate	16	$370	$23
Oxcarbazepine	17	$369	$22
Quetiapine	26	$366	$14
Buprenorphine-Naloxone	15	$360	$24
Clonazepam	40	$298	$7
Propranolol	46	$296	$6
Zolpidem	21	$278	$13
Lorazepam	34	$270	$8
Topiramate	20	$232	$12
Fluoxetine	47	$223	$5
Diazepam	12	$85	$7
Citalopram Hbr	15	$81	$5
Escitalopram	11	$73	$7

Year by year

Sort by

Part D prescribing by year

2024	2,518	113	0% (0)	6%	$410,156
2023	2,271	120	0% (0)	None	$399,135
2022	2,597	142	0% (0)	None	$465,586
2021	2,924	119	0% (0)	None	$422,323
2020	1,814	76	0% (0)	None	$240,251
2019	27	None	0% (0)	None	$3,045

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 42 drugs

Sort by

Part D drugs prescribed in 2023

Invega Sustenna	52	$168,267	$3,236
Lybalvi	31	$46,335	$1,495
Abilify Maintena	11	$30,204	$2,746
Risperdal Consta	15	$20,927	$1,395
Clozapine	98	$9,702	$99
Olanzapine	151	$5,576	$37
Divalproex	133	$4,731	$36
Fluphenazine	24	$4,201	$175
Aripiprazole	82	$4,020	$49
Haloperidol	102	$2,762	$27
Prazosin	73	$2,695	$37
Naltrexone	16	$2,553	$160
Vilazodone	21	$2,229	$106
Bupropion Xl	47	$2,077	$44
Atomoxetine	14	$2,076	$148
Divalproex Sodium Er	57	$1,952	$34
Trazodone	132	$1,789	$14
Buprenorphine-Naloxone	13	$1,727	$133
Hydroxyzine	48	$1,714	$36
Ziprasidone	12	$1,611	$134
Duloxetine	80	$1,544	$19
Buspirone	56	$1,457	$26
Fluvoxamine Maleate	20	$1,440	$72
Gabapentin	66	$1,331	$20
Risperidone	87	$1,285	$15
Benztropine Mesylate	107	$1,127	$11
Hydroxyzine Pamoate	60	$939	$16
Oxcarbazepine	14	$883	$63
Fluoxetine	50	$849	$17
Lamotrigine	82	$830	$10
Clonazepam	49	$641	$13
Sertraline	53	$565	$11
Quetiapine	44	$523	$12
Propranolol	16	$433	$27
Topiramate	36	$423	$12
Zolpidem	33	$327	$10
Venlafaxine Hcl Er	28	$323	$12
Lithium Carbonate	28	$288	$10
Lorazepam	24	$248	$10
Clonidine	12	$149	$12
Citalopram Hbr	19	$121	$6
Diazepam	12	$94	$8

2022: 50 drugs

Sort by

Part D drugs prescribed in 2022

Invega Sustenna	49	$151,451	$3,091
Lybalvi	30	$43,720	$1,457
Vraylar	30	$38,272	$1,276
Risperdal Consta	22	$26,595	$1,209
Latuda	13	$15,673	$1,206
Aripiprazole	106	$15,012	$142
Clozapine	124	$11,821	$95
Paliperidone Er	15	$4,970	$331
Fluphenazine	16	$4,808	$301
Olanzapine	138	$4,746	$34
Ziprasidone	33	$3,805	$115
Naltrexone	29	$3,676	$127
Viibryd	12	$3,623	$302
Vilazodone	12	$3,534	$294
Bupropion Xl	76	$2,865	$38
Duloxetine	103	$2,572	$25
Haloperidol	69	$2,512	$36
Divalproex	97	$2,496	$26
Trazodone	117	$2,209	$19
Divalproex Sodium Er	49	$2,173	$44
Buspirone	64	$1,838	$29
Prazosin	45	$1,828	$41
Zolpidem Tartrate Er	13	$1,822	$140
Risperidone	134	$1,638	$12
Hydroxyzine	56	$1,622	$29
Fluvoxamine Maleate	13	$1,523	$117
Lamotrigine	123	$1,385	$11
Benztropine Mesylate	101	$1,137	$11
Amantadine	12	$1,108	$92
Gabapentin	59	$1,043	$18
Quetiapine	80	$1,037	$13
Clonazepam	73	$971	$13
Oxcarbazepine	19	$890	$47
Hydroxyzine Pamoate	49	$880	$18
Fluoxetine	60	$818	$14
Isopto Atropine	13	$672	$52
Venlafaxine Hcl Er	43	$653	$15
Lithium Carbonate Er	35	$571	$16
Propranolol Hcl Er	11	$510	$46
Sertraline	47	$494	$11
Citalopram Hbr	43	$375	$9
Lorazepam	44	$347	$8
Zolpidem	30	$298	$10
Bupropion	12	$278	$23
Topiramate	25	$276	$11
Alprazolam	22	$246	$11
Bupropion Hcl Sr	14	$239	$17
Mirtazapine	18	$160	$9
Escitalopram	21	$122	$6
Clonidine	15	$75	$5

2021: 48 drugs

Sort by

Part D drugs prescribed in 2021

Invega Sustenna	32	$96,415	$3,013
Latuda	39	$63,010	$1,616
Aripiprazole	108	$25,823	$239
Clozapine	144	$16,727	$116
Vraylar	11	$13,062	$1,187
Viibryd	33	$9,981	$302
Fluphenazine	16	$5,280	$330
Paliperidone Er	16	$4,948	$309
Olanzapine	171	$3,899	$23
Ziprasidone	57	$3,733	$65
Perphenazine	21	$3,480	$166
Duloxetine	111	$3,387	$31
Prazosin	97	$3,281	$34
Naltrexone	22	$3,222	$146
Divalproex Sodium Er	34	$2,574	$76
Bupropion Xl	77	$2,560	$33
Trazodone	160	$2,512	$16
Haloperidol	58	$2,073	$36
Buspirone	115	$1,947	$17
Divalproex	61	$1,805	$30
Benztropine Mesylate	140	$1,745	$12
Quetiapine	118	$1,654	$14
Chlorpromazine	13	$1,525	$117
Lamotrigine	137	$1,502	$11
Hydroxyzine Pamoate	85	$1,480	$17
Risperidone	99	$1,290	$13
Amantadine	22	$1,258	$57
Fluvoxamine Maleate	14	$1,199	$86
Bupropion Hcl Sr	26	$1,181	$45
Gabapentin	78	$1,081	$14
Hydroxyzine	51	$1,073	$21
Quetiapine Fumarate Er	13	$1,040	$80
Fluoxetine	80	$913	$11
Sertraline	68	$878	$13
Clonazepam	93	$762	$8
Oxcarbazepine	22	$712	$32
Lorazepam	65	$664	$10
Venlafaxine Hcl Er	47	$544	$12
Lithium Carbonate Er	24	$439	$18
Propranolol Hcl Er	12	$432	$36
Bupropion	12	$416	$35
Escitalopram	41	$298	$7
Zolpidem	31	$283	$9
Alprazolam	21	$229	$11
Citalopram Hbr	22	$182	$8
Lactulose	15	$162	$11
Topiramate	36	$140	$4
Clonidine	17	$94	$6

2020: 38 drugs

Sort by

Part D drugs prescribed in 2020

Invega Sustenna	15	$43,532	$2,902
Latuda	17	$33,544	$1,973
Risperdal Consta	13	$21,159	$1,628
Aripiprazole	97	$20,798	$214
Rexulti	17	$19,756	$1,162
Clozapine	36	$4,955	$138
Viibryd	11	$3,139	$285
Duloxetine	92	$3,120	$34
Prazosin	72	$3,088	$43
Ziprasidone	22	$2,337	$106
Olanzapine	108	$2,036	$19
Perphenazine	12	$2,027	$169
Bupropion Xl	64	$1,956	$31
Amantadine	24	$1,810	$75
Trazodone	113	$1,685	$15
Divalproex Sodium Er	40	$1,566	$39
Haloperidol	22	$1,513	$69
Clonazepam	98	$1,092	$11
Hydroxyzine	37	$1,061	$29
Lamotrigine	109	$914	$8
Lorazepam	54	$842	$16
Venlafaxine Hcl Er	29	$806	$28
Divalproex	32	$768	$24
Oxcarbazepine	26	$741	$29
Benztropine Mesylate	73	$719	$10
Hydroxyzine Pamoate	49	$675	$14
Sertraline	64	$668	$10
Buspirone	75	$631	$8
Risperidone	58	$615	$11
Quetiapine	52	$605	$12
Bupropion Hcl Sr	31	$490	$16
Fluoxetine	34	$446	$13
Zolpidem	32	$380	$12
Lithium Carbonate Er	16	$279	$17
Clonidine	29	$199	$7
Gabapentin	19	$139	$7
Escitalopram	12	$104	$9
Topiramate	11	$27	$2

Money from drug and device companies

$123 in 2025

Sort by

Industry payments by year

2025	1	1	None	$123
2024	4	6	None	$499
2023	1	1	None	$30
2022	3	10	None	$402
2021	1	6	$4,875	$6,017

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Axsome Therapeutics	Auvelity	$123	1 payment Meals for Auvelity · 2025-01-28 · $123

See the published payment

Sort by

Every published payment

Axsome Therapeutics	Meals · 2025-01-28	Auvelity	$123

See earlier years (2024, 2023, 2022, 2021)

2024: $499

Sort by

Payments by company in 2024

Alkermes	Lybalvi	$253	3 payments Meals for Lybalvi · 2024-11-14 · $122 Meals for Lybalvi · 2024-02-29 · $120 Meals for Aristada · 2024-01-31 · $12
Janssen Pharmaceuticals	Spravato	$118	1 payment Meals for Spravato · 2024-04-04 · $118
Neurocrine Biosciences	Ingrezza	$100	1 payment Meals for Ingrezza · 2024-06-12 · $100
Otsuka Pharmaceutical Development & Commercialization	None	$27	1 payment Meals · 2024-08-14 · $27

2023: $30

Sort by

Payments by company in 2023

Otsuka Pharmaceutical Development & Commercialization	None	$30	1 payment Meals · 2023-01-26 · $30

2022: $402

Sort by

Payments by company in 2022

Otsuka America Pharmaceutical	Rexulti	$166	4 payments Meals for Abilify Maintena · 2022-12-10 · $25 Meals for Abilify Maintena · 2022-10-08 · $11 Meals for Rexulti · 2022-05-18 · $123 Meals for Abilify Maintena · 2022-02-11 · $7
Alkermes	Lybalvi	$132	4 payments Meals for Lybalvi · 2022-06-15 · $100 Meals for Aristada · 2022-06-08 · $18 Meals for Aristada · 2022-05-19 · $8 Meals for Aristada · 2022-02-04 · $6
Janssen Pharmaceuticals	Spravato	$104	2 payments Meals for Spravato · 2022-06-08 · $39 Meals for Spravato · 2022-01-19 · $65

2021: $6,017

Sort by

Payments by company in 2021

Janssen Pharmaceuticals	Spravato	$6,017	6 payments Consulting for Spravato · 2021-12-08 · $4,875 Meals for Spravato · 2021-12-04 · $9 Travel for Spravato · 2021-12-04 · $1,048 Meals for Spravato · 2021-12-04 · $27 Meals for Spravato · 2021-12-04 · $13 Meals for Spravato · 2021-12-04 · $45

Professional record

NPI: 1396300984
Licence: WA AP60966586, WA RN60557508Washington ARNP.AP.60966586-NP: ActiveWashington RN.RN.60557508: Active
Gender: Female

More record details

Sole proprietor: Yes
Taxonomy: Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163WP0808X (163WP0808X)
Mailing address: 7080 Hollywood Blvd Ste 815, Los Angeles, CA, 90028
NPI first listed: 2019-05-08
NPI last updated: 2026-05-24
NPI record certified: 2026-05-24

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 28037 121st Ave Se, Kent, WA, 98030 · 325 E Pioneer, Puyallup, WA, 98372